Skip to main content
. 2022 Mar 5;82(5):511–531. doi: 10.1007/s40265-022-01685-4

Fig. 1.

Fig. 1

Overview of mechanism-based pharmacotherapeutic options in complex regional pain syndrome. Experimental therapies are light-coloured and italicised. CRPS complex regional pain syndrome, NMDA N-methyl-d-aspartate, TNF tumour necrosis factor